116 related articles for article (PubMed ID: 8030401)
1. Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results.
Frisoni GB; Pizzolato G; Bianchetti A; Chierichetti F; Ferlin G; Battistin L; Trabucchi M
Acta Neurol Scand; 1994 Mar; 89(3):199-203. PubMed ID: 8030401
[TBL] [Abstract][Full Text] [Related]
2. (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.
Spampinato U; Habert MO; Mas JL; Bourdel MC; Ziegler M; de Recondo J; Askienazy S; Rondot P
J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):787-92. PubMed ID: 1955897
[TBL] [Abstract][Full Text] [Related]
3. Dementia of the frontal type: neuropsychological and [99Tc]-HM-PAO SPET features.
Frisoni GB; Pizzolato G; Geroldi C; Rossato A; Bianchetti A; Trabucchi M
J Geriatr Psychiatry Neurol; 1995 Jan; 8(1):42-8. PubMed ID: 7710647
[TBL] [Abstract][Full Text] [Related]
4. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
[TBL] [Abstract][Full Text] [Related]
5. Single photon emission computed tomography using 99mTc-HM-PAO in the routine evaluation of Alzheimer's disease.
Hurwitz TA; Ammann W; Chu D; Clark C; Holden J; Brownstone R
Can J Neurol Sci; 1991 Feb; 18(1):59-62. PubMed ID: 2036616
[TBL] [Abstract][Full Text] [Related]
6. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia.
Starkstein SE; Migliorelli R; Tesón A; Sabe L; Vázquez S; Turjanski M; Robinson RG; Leiguarda R
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):790-6. PubMed ID: 8021663
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor SPET imaging in Parkinson's disease: a [123I]-IBZM and [99mTc]-HM-PAO study.
Pizzolato G; Chierichetti F; Rossato A; Briani C; Dam M; Borsato N; Saitta B; Zanco P; Ferlin G; Battistin L
Eur Neurol; 1993; 33(2):143-8. PubMed ID: 8467821
[TBL] [Abstract][Full Text] [Related]
8. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
[TBL] [Abstract][Full Text] [Related]
9. CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease--initial results.
Costa DC; Ell PJ; Burns A; Philpot M; Levy R
J Cereb Blood Flow Metab; 1988 Dec; 8(6):S109-15. PubMed ID: 3263977
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological tests and [99mTc]-HM PAO SPECT in the diagnosis of Alzheimer's dementia.
Villa G; Cappa A; Tavolozza M; Gainotti G; Giordano A; Calcagni ML; De Rossi G
J Neurol; 1995 Jun; 242(6):359-66. PubMed ID: 7561963
[TBL] [Abstract][Full Text] [Related]
11. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions.
Smith FW; Besson JA; Gemmell HG; Sharp PF
J Cereb Blood Flow Metab; 1988 Dec; 8(6):S116-22. PubMed ID: 2973469
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias.
Masterman DL; Mendez MF; Fairbanks LA; Cummings JL
J Geriatr Psychiatry Neurol; 1997 Jan; 10(1):15-21. PubMed ID: 9100154
[TBL] [Abstract][Full Text] [Related]
13. Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM.
Pizzolato G; Chierichetti F; Fabbri M; Cagnin A; Dam M; Ferlin G; Battistin L
Neurology; 1996 Oct; 47(4):1065-8. PubMed ID: 8857746
[TBL] [Abstract][Full Text] [Related]
14. Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia.
Neary D; Snowden JS; Shields RA; Burjan AW; Northen B; MacDermott N; Prescott MC; Testa HJ
J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1101-9. PubMed ID: 3499484
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
[TBL] [Abstract][Full Text] [Related]
16. The use of [99mTc]-HM-PAO in the diagnosis of primary degenerative dementia.
Testa HJ; Snowden JS; Neary D; Shields RA; Burjan AW; Prescott MC; Northen B; Goulding P
J Cereb Blood Flow Metab; 1988 Dec; 8(6):S123-6. PubMed ID: 3263978
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral blood flow and aberrant motor behaviour in Alzheimer's disease.
Reilly TJ; Staff RT; Ahearn TS; Bentham P; Wischik CM; Murray AD
Behav Brain Res; 2011 Sep; 222(2):375-9. PubMed ID: 21507335
[TBL] [Abstract][Full Text] [Related]
18. Event-related potential prolongation in Alzheimer's disease signifies frontal lobe impairment: evidence from SPECT imaging.
O'Mahony D; Coffey J; Murphy J; O'Hare N; Hamilton D; Rowan M; Freyne P; Walsh JB; Coakley D
J Gerontol A Biol Sci Med Sci; 1996 May; 51(3):M102-7. PubMed ID: 8630702
[TBL] [Abstract][Full Text] [Related]
19. Age at onset and SPECT imaging in Alzheimer's disease.
Caffarra P; Scaglioni A; Malvezzi L; Previdi P; Spreafico L; Salmaso D
Dementia; 1993; 4(6):342-6. PubMed ID: 8136898
[TBL] [Abstract][Full Text] [Related]
20. [Single photon emission computed tomography in the diagnosis of Alzheimer's disease].
Hanyu H; Asano T; Abe S; Arai H; Takasaki M; Shindo H; Abe K
Nihon Ronen Igakkai Zasshi; 1997 Jun; 34(6):468-73. PubMed ID: 9301261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
